Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers

Vaccine

Volumn 14, Issue 1, 1996, Pages 19-24

  Hohmann, Elizabeth L ^a   Oletta, Carmen A ^a   Miller, Samuel I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical trials; Microbial pathogenesis; Salmonella typhi

Indexed keywords

IMMUNOGLOBULIN G; LIVE VACCINE; TYPHOID VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA TYPHI; SEROCONVERSION; TYPHOID FEVER; VACCINATION;

EID: 0030028340     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00173-X     Document Type: Article

References (31)

1. Tacket, C., Hone, D., Curtiss, III, R. et al. Comparison of the safety and immunogenicity of ΔaroCΔaroD and ΔcyaΔcrp S. typhi strains in human volunteers. Infect. Immun. 1992, 60, 536-541
2. Carter, P. and Collins, F. The route of enteric infection in normal mice. J. Exp. Med. 1974, 139, 1189-1203
3. Germainer, R. Immunity in experimental salmonellosis. I. Protection induced by rough mutants of Salmonella typhimurium. Infect. Immun. 1970, 2, 309-315
4. Tacket, C., Hone, D., Losonsky, G., Guers, L., Edelman, R. and Levine, M.M. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 1992, 10, 443-446
5. Miller, S.I., Kukral, A. and Mekalanos, J.J. A two component regulatory system phoP/phoQ controls Salmonella typhimurium virulence. Proc. Natl Acad. Sci. USA 1989, 86, 5054-5058
6. Groisman, E., Chiao, E., Lipps, C. and Heffron, F. Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc. Natl Acad. Sci. USA 1989, 86, 7077-7081
7. Pulkkinen, W.P. and Miller, S.I. A S. typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J. Bacteriol. 1991, 173, 86-93
8. Behlau, I. and Miller, S.I. A phoP-repressed gene promotes S. typhimurium invasion of epithelial cells. J. Bacteriol. 1993, 175, 4475-4484
9. Beiden, B. and Miller, S.I. Further characterization of the PhoP regulon: identification of new pag virulence loci. Infect. Immun. 1994, 62, 5095-5101
10. Galan, J. and Curtiss, III, R. Virulence and vaccine potential of phoP mutants of S. typhimurium. Microb. Pathog. 1989, 6, 422-443
11. Fields, P., Swanson, R., Haidaris, C. and Heffron, F. Mutants of S. typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl Acad. Sci. USA 1986, 83, 5189-5193
12. Hone, D., Attridge, S., Forrest, B. et al. A ga/E via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 1988, 56, 1326-1333
13. Edwards, M.F. and Stocker, B.A.D. Construction of ΔaroA ΔpurA strains of Salmonella typhi. J. Bacteriol. 1988, 170, 3991-3995
14. Levine, M.M., Herrington, D., Murphy, J. et al. Safety, infectivity, immunogenicity and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 1987, 79, 888-902
15. Blofield, I., Vaughn, V., Rest, R. and Eisenstein, B. Allelic exchange in E. coli using the Bacillus subtilis sacB gene and a temperature sensitive pSC101 replicon. Mol. Microbiol. 1991, 5, 1447-1457
16. Donnenberg, M. and Kaper, J. Construction of an eae deletion mutant of enteropathogenic E. coli by using a positive-selection suicide vector. Infect. Immun. 1991, 59, 4310-4317
17. Davis, R.W., Botstein, D. and Roth, J.R. Advanced Bacterial Genetics: a Manual for Genetic Engineering. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1980
18. Miller, S.I., Pulkkinen, W.P., Selsted, M. and Mekalanos, J.J. Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of S. typhimurium. Infect. Immun. 1990, 58, 3706-3701
19. Levine, M., Kaper, J. and Herrington, D. Safety, immunogenicity and efficacy of recombinant live oral cholera vaccine, CVD 103 and CVD 103-HgR. Lancet 1988, 2, 467-470
20. Tacket, C., Losonsky, G., Taylor, D. et al. Lack of response to the Vi component of the Salmonella typhi live oral vaccine strain Ty21a in human studies. J. Infect. Dis. 1991, 163, 901-904
21. Levine, M.M. Typhoid fever vaccines. In: Vaccines (Eds Plotkin, S.A. and Mortimer, E.A.). W.B. Saunders, Philadelphia, 1994, pp. 597-633
22. Forrest, B.D. Impairment of immunogenicity of Salmonella typhi Ty21a due to preexisting cross reacting intestinal antibodies. J. Infect. Dis. 1992, 166, 210-211
23. Levine, M.M., Ferreccio, C., Black, R.E., Tacket, C.O. and Germanier, L.R. Progress in vaccines to prevent typhoid fever. Rev. Infect. Dis. 1989, 11(S3), S552-S567
24. Smith, B.P., Reina-Guerra, M., Stocker, B.A.D., Hoiseth, S.K. and Johnson, E.H. Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am. J. Vet. Res. 1984, 45, 2231-2235
25. Gonzales, C., Hone, D., Noriega, F.R. et al. Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J. Infect. Dis. 1994, 169, 927-931
26. Forrest, B.D., LaBrooy, J.T., Beyer, L., Dearlove, C.E. and Shearman, D.J.C. The human humoral immune response to Salmonella typhi Ty21a. J. Infect. Dis. 1991, 163, 336-345
27. Fayolle, C., Callaghan, D.O., Martineau, P. et al. Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium. Infect. Immun. 1994, 62, 4310-4319
28. Wick, M.J., Harding, C.V., Normark, S.J. and Pfeifer, J.D. Parameters that influence the efficiency of processing antigenic epitopes in Salmonella typhimurium. Infect. Immun. 1994, 62, 4542-4548
29. Cardenas, L. and Clements, J.D. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 1993, 11, 126-135
30. Cardenas, L., Dasgupta, U. and Clements, J.D. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 1994, 12, 833-840
31. Wick, M.J., Harding, C.V., Twesten, N.J., Normark, S.J. and Pfeifer, J.D. The phoP locus influences processing and presentation of S. typhimurium antigens by activated macrophages. Mol. Microbiol. 1995, 16, 465-470